These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33208078)

  • 1. Micro-RNA (miRNA): A Biomarker to Identify Novel Compounds in Drug Discovery and Delivery for Cancer Therapy.
    Paramasivam G
    Curr Drug Discov Technol; 2021; 18(6):e130921188092. PubMed ID: 33208078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA-BD: an evidence-based bioinformatics model and software tool for microRNA biomarker discovery.
    Lin Y; Wu W; Sun Z; Shen L; Shen B
    RNA Biol; 2018; 15(8):1093-1105. PubMed ID: 30081733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
    Schrauder MG; Strick R; Schulz-Wendtland R; Strissel PL; Kahmann L; Loehberg CR; Lux MP; Jud SM; Hartmann A; Hein A; Bayer CM; Bani MR; Richter S; Adamietz BR; Wenkel E; Rauh C; Beckmann MW; Fasching PA
    PLoS One; 2012; 7(1):e29770. PubMed ID: 22242178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as Biomarker for Breast Cancer.
    Aggarwal T; Wadhwa R; Gupta R; Paudel KR; Collet T; Chellappan DK; Gupta G; Perumalsamy H; Mehta M; Satija S; Hansbro PM; Dua K; Maurya PK
    Endocr Metab Immune Disord Drug Targets; 2020; 20(10):1597-1610. PubMed ID: 32342824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA Biomarkers in Breast Cancer Detection and Management.
    Fu SW; Chen L; Man YG
    J Cancer; 2011 Feb; 2():116-22. PubMed ID: 21479130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer.
    Ranjha R; Paul J
    Inflamm Res; 2013 Apr; 62(4):343-55. PubMed ID: 23417288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs: non coding pleiotropic factors in development, cancer prevention and treatment.
    Fazi F; Blandino G
    Microrna; 2013; 2(2):81. PubMed ID: 25070777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
    Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
    Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inferring coregulation of transcription factors and microRNAs in breast cancer.
    Wu JH; Sun YJ; Hsieh PH; Shieh GS
    Gene; 2013 Apr; 518(1):139-44. PubMed ID: 23246694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA: Promising Roles in Cancer Therapy.
    Hashemi A; Gorji-Bahri G
    Curr Pharm Biotechnol; 2020; 21(12):1186-1203. PubMed ID: 32310047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in breast cancer pathogenesis.
    Götte M
    Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in microRNA delivery.
    Zhang Y; Wang Z; Gemeinhart RA
    J Control Release; 2013 Dec; 172(3):962-74. PubMed ID: 24075926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeutics.
    Muthiah M; Park IK; Cho CS
    Expert Opin Drug Deliv; 2013 Sep; 10(9):1259-73. PubMed ID: 23826971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability.
    Naser Al Deen N; Nassar F; Nasr R; Talhouk R
    Adv Exp Med Biol; 2019; 1152():335-364. PubMed ID: 31456193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy plays a dual role during intracellular siRNA delivery by lipoplex and polyplex nanoparticles.
    Song W; Ma Z; Zhang Y; Yang C
    Acta Biomater; 2017 Aug; 58():196-204. PubMed ID: 28528119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstruction of temporal activity of microRNAs from gene expression data in breast cancer cell line.
    Jayavelu ND; Bar N
    BMC Genomics; 2015 Dec; 16():1077. PubMed ID: 26763900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum microRNAs as powerful cancer biomarkers.
    Wittmann J; Jäck HM
    Biochim Biophys Acta; 2010 Dec; 1806(2):200-7. PubMed ID: 20637263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold nanoparticle-based 2'-O-methyl modified DNA probes for breast cancerous theranostics.
    Li J; Huang J; Yang X; Yang Y; Quan K; Xie N; Wu Y; Ma C; Wang K
    Talanta; 2018 Jun; 183():11-17. PubMed ID: 29567152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.
    Ward A; Shukla K; Balwierz A; Soons Z; König R; Sahin O; Wiemann S
    J Pathol; 2014 Aug; 233(4):368-79. PubMed ID: 24752803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.